Diagnos Statistics
Want to see TSE:ADK full AI Analyst Report?
Diagnos (ADK) Stock Statistics & Valuation Metrics
Total Valuation
Diagnos has a market cap or net worth of CAD 39.74M. The enterprise value is CAD 32.59M.
- Market Cap
- CAD 39.74M
- Enterprise Value
- CAD 32.59M
Share Statistics
Diagnos has 120,412,550 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 120,412,550
- Owned by Insiders
- 5.65%
- Owned by Institutions
- 0.25%
Financial Efficiency
Diagnos’s return on equity (ROE) is -6.63 and return on invested capital (ROIC) is -204.11%.
- Return on Equity (ROE)
- -6.63
- Return on Assets (ROA)
- -1.91
- Return on Invested Capital (ROIC)
- -204.11%
- Return on Capital Employed (ROCE)
- -4.67
- Revenue Per Employee
- 4,092.313
- Profits Per Employee
- -284.70K
- Employee Count
- 16
- Asset Turnover
- 0.03
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Diagnos is -7.99. Diagnos’s PEG ratio is -0.58.
- PE Ratio
- -7.99
- PS Ratio
- 606.86
- PB Ratio
- 57.85
- Price to FCF
- -10.28
- Price to Operating Cash Flow
- -10.31
- PEG Ratio
- -0.58
Income Statement
In the last 12 months, Diagnos had revenue of 65.48K and earned -4.56M in profits. Earnings per share was -0.04.
- Revenue
- 65.48K
- Gross Profit
- -119.45K
- Operating Income
- -4.26M
- Pretax Income
- -4.56M
- Net Income
- -4.56M
- EBITDA
- -4.13M
- Earnings Per Share (EPS)
- -0.04
Cash Flow
In the last 12 months, operating cash flow was -3.86M and capital expenditures -11,066, giving a free cash flow of -3.87M billion.
- Operating Cash Flow
- -3.86M
- Free Cash Flow
- -3.87M
- Free Cash Flow per Share
- -0.03
Dividends & Yields
Diagnos pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -9.73%
- Earnings Yield
- -11.46%
Stock Price Statistics
- Beta
- 0.55
- 52-Week Price Change
- 17.86%
- 50-Day Moving Average
- 0.42
- 200-Day Moving Average
- 0.31
- Relative Strength Index (RSI)
- 32.30
- Average Volume (3m)
- 228.48K
Important Dates
Diagnos upcoming earnings date is Dec 01, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 20, 2026
- Next Earnings Date
- Dec 01, 2026
- Ex-Dividend Date
- ―
Financial Position
Diagnos as a current ratio of 1.49, with Debt / Equity ratio of 204.05%
- Current Ratio
- 1.49
- Quick Ratio
- 1.49
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- -0.26
- Interest Coverage Ratio
- -11.06
Taxes
In the past 12 months, Diagnos has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Diagnos EV to EBITDA ratio is -9.97, with an EV/FCF ratio of -10.56.
- EV to Sales
- 623.54
- EV to EBITDA
- -9.97
- EV to Free Cash Flow
- -10.56
- EV to Operating Cash Flow
- -10.59
Balance Sheet
Diagnos has CAD 1.93M in cash and marketable securities with CAD 1.40M in debt, giving a net cash position of CAD 525.14K billion.
- Cash & Marketable Securities
- CAD 1.93M
- Total Debt
- CAD 1.40M
- Net Cash
- CAD 525.14K
- Net Cash Per Share
- CAD 0.00
- Tangible Book Value Per Share
- CAD 0.01
Margins
Gross margin is -182.42%, with operating margin of -6510.52%, and net profit margin of -6956.84%.
- Gross Margin
- -182.42%
- Operating Margin
- -6510.52%
- Pretax Margin
- -6956.84%
- Net Profit Margin
- -6956.84%
- EBITDA Margin
- -6251.16%
- EBIT Margin
- -6448.88%
Analyst Forecast
The average price target for Diagnos is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -36.92%
- EPS Growth Forecast
- 13.03%
Scores
- Smart Score
- 7
- AI Score
- 43

